On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Antifungal resistance and susceptibility

TopicLeading institutions, researchers & key papers

Antifungal resistance and susceptibility is a topic indexed in ScholarIQ from OpenAlex.

What is known about Antifungal resistance and susceptibility?

ScholarIQrecord summary

This cluster of papers covers the diagnosis, management, epidemiology, and treatment of various fungal infections such as candidiasis, aspergillosis, mucormycosis, and biofilm-related infections. It also discusses antifungal therapy, resistance mechanisms, and the impact of these infections on immunocompromised patients.

How many works does Antifungal resistance and susceptibility have?

ScholarIQindexed works

Antifungal resistance and susceptibility has 166 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Antifungal resistance and susceptibility?

ScholarIQopenalex

The OpenAlex for Antifungal resistance and susceptibility is on the source record.

What are the most-cited papers on Antifungal resistance and susceptibility?

ScholarIQmost cited works
A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
Jesse L. Goodman, Drew J. Winston, Ronald A. Greenfield, Pranatharthi Chandrasekar, Barry Fox, Herbert Kaizer, Richard K. Shadduck, Thomas C. Shea, Patrick J. Stiff, David J. Friedman, William G. Powderly, Jeffrey L. Silber, Harold W. Horowitz, Alan Lichtin, Steven N. Wolff, Kenneth F. Mangan, Samuel Silver, Daniel J. Weisdorf, Winston G. Ho, Gene Gilbert, Donald N. Buell
New England Journal of Medicine. 19921,182 Citations
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Awadhesh Kumar Singh, Ritu Singh, Shashank Joshi, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews. 20211,107 CitationsOPEN ACCESS
Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Christopher D. Pfeiffer, Jason P. Fine, Nasia Safdar
Clinical Infectious Diseases. 2006957 Citations
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz, Johan Maertens, Lindsey R. Baden, Anna Dmoszyńska, Oliver A. Cornely, Michael Bourque, Robert Lupinacci, Carole A. Sable, Ben E. dePauw
New England Journal of Medicine. 2004922 CitationsOPEN ACCESS
Epidemiology and Etiology of Denture Stomatitis
Linda Gendreau, Zvi G. Loewy
Journal of Prosthodontics. 2011834 Citations

Where is Antifungal resistance and susceptibility research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Antifungal resistance and susceptibility is open access?

ScholarIQopen access share
60%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
0%
Bronze
47%
Closed
40%

Related on ScholarIQ

470M+ articles · 14-day free trial